Latest filing published 15 Mar 2022 for CYTOKINETICS INC, €63k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark A. Schlossberg: trading record in brief
Mark A. Schlossberg is a declared insider at 2 companies (senior executive); the most frequent names are Impax Laboratories, LLC and Cytokinetics Inc. Over a trading history stretching from 8 July 2011 to 15 March 2022, the count stands at 49 filings.
The open-market side counts 1 purchase for €13k alongside 6 sales for €2.3M. Sales outweigh purchases by €2.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 34 share grants and 6 option exercises. 2022 to date brings no purchases and 1 sale.
The record was last updated on 15 March 2022 with an option exercise (€63k) in Cytokinetics Inc. The last insider purchase was made public on 14 March 2013, 4,987 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Mark A. Schlossberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,803 shares@ US$14.402.1% of flowCommon StockSEC:0001061983-22-000077:1
- 25,196 shares@ US$14.4011.1% of flowCommon StockSEC:0001061983-22-000077:2
- 25,196 shares@ US$33.9626.3% of flowCommon StockSEC:0001061983-22-000077:3
- 30,818 shares@ US$7.0333.4% of flowCommon StockSEC:0001061983-22-000077:0
- 4,631 shares@ US$36.8326.5% of flowCommon StockSEC:0001061983-22-000070:0
- 20,000 shares0Common StockSEC:0001061983-22-000056:1
- 3,457 shares@ US$37.6319.7% of flowCommon StockSEC:0001061983-22-000056:0
- 3,125 shares0Common StockSEC:0001061983-22-000028:1
- 1,900 shares0Common StockSEC:0001061983-22-000028:0
- 19,979 shares@ US$35.7434.1% of flowCommon StockSEC:0001061983-21-000241:1
- 19,979 shares@ US$7.0320.4% of flowCommon StockSEC:0001061983-21-000241:0
- 4,150 shares@ US$19.193.7% of flowCommon StockSEC:0001061983-21-000078:0
- 25,000 shares0Common StockSEC:0001061983-21-000061:0
- 10,000 shares@ US$7.035.3% of flowCommon StockSEC:0001061983-20-000143:0
- 10,000 shares@ US$25.0018.8% of flowCommon StockSEC:0001061983-20-000143:1
- 10,000 shares@ US$7.035.3% of flowCommon StockSEC:0001061983-20-000135:0
- 10,000 shares@ US$23.0717.5% of flowCommon StockSEC:0001061983-20-000135:1
- 30,000 shares0Common StockSEC:0001061983-20-000064:0
- 50,116 sharesCommon StockSEC:0001003642-18-000081:0
- 18,135 sharesRestricted Common StockSEC:0001003642-18-000081:1
- 3,273 shares@ US$19.509.6% of flowCommon StockSEC:0001003642-18-000047:0
- 5,937 shares@ US$20.9518.6% of flowCommon StockSEC:0001003642-18-000022:0
- 3,235 shares@ US$17.659.6% of flowCommon StockSEC:0001003642-17-000046:0
- 3,488 shares@ US$16.809.8% of flowCommon StockSEC:0001003642-17-000046:1
- 23,272 shares0Common StockSEC:0001003642-17-000020:0
25 of 49 declarations
